State
20,083 recalls have nationwide distribution and so reach Massachusetts. 0 additional recalls listed Massachusetts specifically in their distribution scope.
Most US product recalls have nationwide distribution — the manufacturer ships into every state and the recall sweeps the same way. We include those in this listing because they affect Massachusetts consumers even though the source notice doesn’t name the state. State-specific recalls are usually for products with regional distribution (a regional dairy, a local store brand) or where the agency was able to narrow the affected shipments to specific destinations.
If you’re checking whether a recall affects your purchase, the recall detail page lists the exact production lot codes, UPCs, and best-by dates. Match those against your package — distribution scope is a starting filter, not the final answer.
Granules Pharmaceuticals is recalling Colchicine 0.6 mg capsules nationwide due to failed dissolution specifications detected during stability testing. Patients should contact their healthcare provider for guidance.
Fresenius Medical Care is recalling Dialyzer Optiflux 160NRe units nationwide due to potential internal blood leaks caused by cracked polyurethane in the dialyzer material.
Eugia US LLC is recalling Progesterone Injection due to a market complaint of glass particles found in vials. The affected batch poses a potential risk to patients who receive injections from contaminated vials.
Beckman Coulter is recalling Access PTH assay reagent packs from lot 339071 due to under- or over-filling in well 0, which could cause sealing issues, contamination, and inaccurate test results.
Certain Tec 6 Plus and Tec 800 series anesthesia vaporizers may deliver less anesthetic agent than the dial setting indicates due to a manufacturing issue. Approximately 1,573 units are affected, distributed in the United States and globally.
Greiner Bio-One GmbH is recalling VACUETTE SAFELINK blood collection holders because the protective rubber sleeve may bunch up and fail to retract, causing potential blood leakage from the device.
Rising Pharma recalls Duloxetine DR Capsules 60 mg nationwide due to N-nitroso-duloxetine impurity levels exceeding FDA limits. Affected batches were distributed nationwide; check lot numbers on bottle labels for affected product.
Amerisource Health Services LLC is recalling Clobazam 10 mg tablets due to the presence of foreign tablets or capsules in some packages. The recall affects 5,178 cartons with Lot #1019594 distributed nationwide.
Eugia US LLC is recalling medroxyprogesterone acetate injectable suspension (150mg/mL) due to manufacturing practice deviations. This voluntary recall affects 19,872 vials distributed nationwide.
FDC Limited is recalling 136,181 bottles of Ciprofloxacin Ophthalmic Solution due to defective packaging where the cap spike is lodged in the bottle nozzle, preventing product dispensing.
GE Medical Systems is recalling approximately 928 Tec 820 SEV anesthesia vaporizers due to a manufacturing defect that can cause them to deliver less anesthetic agent than the dial setting indicates. The devices are distributed nationwide and globally.
GE Medical Systems recalls Tec 850 SEV anesthesia vaporizers due to a manufacturing defect that may cause them to deliver less anesthetic agent than the dial setting indicates. Affected devices distributed nationwide and globally.
Rising Pharma is recalling certain batches of Duloxetine Delayed-Release Capsules 30 mg due to a manufacturing deviation that resulted in elevated N-nitroso-duloxetine impurity above FDA's recommended interim limit.
Aerin Medical is recalling 479 units of VivAer Stylus (Lot #10235) due to incorrect programming in units from a single lot. When connected to the Aerin Console, affected devices will be incorrectly identified as RhinAer Stylus.
Jubilant Draximage is recalling 5,209 kits of Technetium Tc 99m Sulfur Colloid Injection that failed stability specifications. The affected lots (C2300070, C2300070E) were distributed nationwide.
West-Ward Columbus is recalling Methadone Hydrochloride Tablets, 5mg, in unit-dose packaging due to illegible product identification on individual tablets. Lot AC2556A was distributed nationwide.
Ford is recalling 2025 Maverick vehicles with defectively manufactured cylinder heads that can leak oil. The leak increases the risk of fire and engine failure.
Ford is recalling certain 2025 Lincoln Navigator vehicles. The rear lightbar may develop cracks allowing moisture accumulation, potentially disabling reverse lights and reducing visibility when backing up.
KTM and Husqvarna are recalling certain 2024-2025 motorcycles because faulty engine control software may cause the engine to stall at low RPMs, creating a risk of crashes.
Ford is recalling certain 2025 Escape vehicles because liftgate hinge covers may not be properly secured and can detach. Detached covers can create a distraction or road hazard, increasing crash risk.
Daimler Vans USA is recalling 2019-2022 Mercedes-Benz Sprinter vehicles. The instrument cluster illumination may be too bright and non-adjustable, making it difficult for drivers to see critical safety information and increasing crash risk.
Chrysler is recalling 2025-2026 RAM pickup trucks (1500, 2500, 3500, 4500, 5500) because a software error causes the instrument panel display to go blank, preventing drivers from seeing critical warning lights and gear selection.
Ford is recalling 679 2025 Expedition, Ranger, F-150, Bronco, and Navigator vehicles due to a potential Electronic Brake Booster malfunction that can cause loss of power brake assist, increasing crash risk.
Toyota is recalling certain 2025 Tacoma and Tacoma Hybrid vehicles because the front driveshaft CV joint may deform and break, impairing steering and risking vehicle rollaway while parked.
Porsche is recalling certain 2021-2024 911 models equipped with optional full bucket seats due to a potential air bag control defect. Unnecessary air bag deployment during a crash could increase injury risk.